Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 25 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4H3Q9
Term | Name | Level | Count |
---|---|---|---|
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016310 | phosphorylation | 5 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0006810 | transport | 3 | 1 |
GO:0006897 | endocytosis | 5 | 1 |
GO:0016192 | vesicle-mediated transport | 4 | 1 |
GO:0051179 | localization | 1 | 1 |
GO:0051234 | establishment of localization | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016301 | kinase activity | 4 | 1 |
GO:0016740 | transferase activity | 2 | 1 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 7 | 11 | PF00656 | 0.383 |
CLV_PCSK_KEX2_1 | 201 | 203 | PF00082 | 0.288 |
CLV_PCSK_KEX2_1 | 292 | 294 | PF00082 | 0.469 |
CLV_PCSK_PC1ET2_1 | 201 | 203 | PF00082 | 0.288 |
CLV_PCSK_PC1ET2_1 | 292 | 294 | PF00082 | 0.440 |
CLV_PCSK_PC7_1 | 288 | 294 | PF00082 | 0.299 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.357 |
DOC_ANK_TNKS_1 | 154 | 161 | PF00023 | 0.479 |
DOC_MAPK_gen_1 | 16 | 22 | PF00069 | 0.458 |
DOC_USP7_UBL2_3 | 221 | 225 | PF12436 | 0.332 |
DOC_USP7_UBL2_3 | 264 | 268 | PF12436 | 0.472 |
LIG_14-3-3_CanoR_1 | 109 | 115 | PF00244 | 0.287 |
LIG_deltaCOP1_diTrp_1 | 242 | 248 | PF00928 | 0.335 |
LIG_deltaCOP1_diTrp_1 | 42 | 48 | PF00928 | 0.374 |
LIG_EH1_1 | 155 | 163 | PF00400 | 0.488 |
LIG_FHA_1 | 297 | 303 | PF00498 | 0.505 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.383 |
LIG_FHA_2 | 33 | 39 | PF00498 | 0.577 |
LIG_FHA_2 | 41 | 47 | PF00498 | 0.400 |
LIG_LIR_Nem_3 | 226 | 231 | PF02991 | 0.329 |
LIG_LIR_Nem_3 | 277 | 283 | PF02991 | 0.464 |
LIG_LYPXL_yS_3 | 280 | 283 | PF13949 | 0.494 |
LIG_Pex14_1 | 44 | 48 | PF04695 | 0.380 |
LIG_Pex14_2 | 59 | 63 | PF04695 | 0.493 |
LIG_REV1ctd_RIR_1 | 99 | 110 | PF16727 | 0.307 |
LIG_SH2_CRK | 112 | 116 | PF00017 | 0.302 |
LIG_SH2_CRK | 26 | 30 | PF00017 | 0.278 |
LIG_SH2_CRK | 73 | 77 | PF00017 | 0.380 |
LIG_SH2_GRB2like | 210 | 213 | PF00017 | 0.288 |
LIG_SH2_NCK_1 | 26 | 30 | PF00017 | 0.502 |
LIG_SH2_SRC | 210 | 213 | PF00017 | 0.288 |
LIG_SH2_STAP1 | 26 | 30 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.273 |
LIG_SH2_STAT5 | 174 | 177 | PF00017 | 0.310 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.442 |
LIG_SH2_STAT5 | 210 | 213 | PF00017 | 0.304 |
LIG_SH3_3 | 292 | 298 | PF00018 | 0.461 |
LIG_SUMO_SIM_par_1 | 299 | 307 | PF11976 | 0.304 |
LIG_UBA3_1 | 143 | 150 | PF00899 | 0.578 |
LIG_WRC_WIRS_1 | 111 | 116 | PF05994 | 0.327 |
MOD_CK1_1 | 66 | 72 | PF00069 | 0.357 |
MOD_CK1_1 | 93 | 99 | PF00069 | 0.443 |
MOD_CK2_1 | 256 | 262 | PF00069 | 0.381 |
MOD_CK2_1 | 297 | 303 | PF00069 | 0.423 |
MOD_CK2_1 | 32 | 38 | PF00069 | 0.666 |
MOD_CK2_1 | 48 | 54 | PF00069 | 0.429 |
MOD_Cter_Amidation | 103 | 106 | PF01082 | 0.288 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.277 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.504 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.285 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.269 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.618 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.422 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.300 |
MOD_PKA_2 | 287 | 293 | PF00069 | 0.432 |
MOD_Plk_2-3 | 36 | 42 | PF00069 | 0.581 |
MOD_Plk_4 | 110 | 116 | PF00069 | 0.327 |
MOD_Plk_4 | 188 | 194 | PF00069 | 0.292 |
MOD_Plk_4 | 256 | 262 | PF00069 | 0.423 |
MOD_Plk_4 | 297 | 303 | PF00069 | 0.410 |
MOD_Plk_4 | 40 | 46 | PF00069 | 0.403 |
MOD_SUMO_rev_2 | 259 | 265 | PF00179 | 0.421 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.296 |
TRG_ENDOCYTIC_2 | 231 | 234 | PF00928 | 0.210 |
TRG_ENDOCYTIC_2 | 26 | 29 | PF00928 | 0.277 |
TRG_ENDOCYTIC_2 | 280 | 283 | PF00928 | 0.490 |
TRG_Pf-PMV_PEXEL_1 | 155 | 159 | PF00026 | 0.378 |
TRG_Pf-PMV_PEXEL_1 | 270 | 274 | PF00026 | 0.560 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HVW7 | Leptomonas seymouri | 77% | 98% |
A0A0N1IIK8 | Leptomonas seymouri | 30% | 89% |
A0A0S4IT41 | Bodo saltans | 52% | 99% |
A0A0S4KIY0 | Bodo saltans | 32% | 89% |
A0A1X0NTG8 | Trypanosomatidae | 28% | 72% |
A0A1X0P8X9 | Trypanosomatidae | 58% | 98% |
A0A3S7X3U7 | Leishmania donovani | 29% | 89% |
A0A451EJU5 | Leishmania donovani | 86% | 98% |
A4HIR9 | Leishmania braziliensis | 29% | 89% |
A4HRY3 | Leishmania infantum | 86% | 98% |
A4I615 | Leishmania infantum | 29% | 89% |
C9ZKJ2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 98% |
E9ACP2 | Leishmania major | 86% | 100% |
E9AJY1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 98% |
E9B1A6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 89% |
Q4Q6V8 | Leishmania major | 29% | 89% |
V5B1N1 | Trypanosoma cruzi | 30% | 91% |
V5DTY1 | Trypanosoma cruzi | 62% | 98% |